P-9 A randomized study of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 as first-line treatment for unresectable metastatic colorectal cancer

Abstract

Conclusion: Elevated postoperative CEA following resection of CRC predicted relapse. However, high preoperative CEA levels that normalized after CRC surgery was not associated with higher relapse.Legal entity responsible for the study: Department of medical oncology.